Abbott Named One of the Top 10 Companies in Calvert Diversity Survey
- Details
- Category: Abbott
![Abbott Abbott](/images/stories/logo/abbott.gif)
Roche obtains license for EGFR lung cancer assays and will develop Tarceva companion diagnostic test
- Details
- Category: Roche
![Roche Roche](/images/stories/logo/roche.gif)
Bayer and Regeneron Report Positive Top-Line Results of Two Phase 3 Studies with VEGF Trap-Eye
- Details
- Category: Bayer
![Bayer Bayer](/images/stories/logo/bayer.gif)
Abbott Announces Positive Results from Phase 2 Study of Low Dose Atrasentan for Treatment of Diabetic Kidney Disease
- Details
- Category: Abbott
![Abbott Abbott](/images/stories/logo/abbott.gif)
APPRAISE-2 Study with Investigational Compound Apixaban Discontinued
- Details
- Category: Bristol-Myers Squibb
![Bristol-Myers Squibb Bristol-Myers Squibb](/images/stories/logo/bms.gif)
Novartis unveils long-term strategy to grow in a dynamically changing healthcare environment
- Details
- Category: Novartis
![Novartis Novartis](/images/stories/logo/novartis_b.gif)
Genzyme Announces Agreement to Sell Diagnostics Business
- Details
- Category: Genzyme
![Genzyme Genzyme](/images/stories/logo/genzyme.gif)
More Pharma News ...
- Pfizer Launches Global Centers for Therapeutic Innovation
- Roche announces implementation plans for its Operational Excellence Program
- Boehringer Ingelheim steps up to the challenge in support of World Diabetes Day
- Adding INSPRA® (eplerenone) to Standard Therapy Significantly Reduces the Risk of CV Mortality and Morbidity
- Rivaroxaban Significantly Reduces Risk of Stroke with Comparable Safety versus Warfarin
- Diabetes awareness survey reveals alarming figures across the Middle East and Northern Africa regions
- Collaboration of Boehringer Ingelheim and VTU Technology